Literature DB >> 16568246

Beta-adrenergic receptors and nitric oxide generation in the cardiovascular system.

L R Queen1, A Ferro.   

Abstract

Nitric oxide plays a crucial role in cardiovascular homeostasis, with important vasodilatory, anti-thrombotic and anti-atherogenic properties. Beta-adrenergic receptors (betaARs), present on a wide variety of cardiovascular cells, including vascular endothelial cells, platelets, cardiac myocytes and leukocytes, have long been established as key players in maintaining cardiovascular homeostatic control. During the last few years a wealth of evidence has emerged which directly links stimulation of these cardiovascular betaARs to nitric oxide (NO) generation, suggesting a new and important mechanism of adrenergic control of cardiovascular function. This review explores the cardiovascular cell systems in which this coupling of betaARs and NO occurs, the intracellular signalling and regulatory mechanisms involved and the abnormalities in betaAR-NO oxide coupling found in cardiovascular disease states.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16568246     DOI: 10.1007/s00018-005-5451-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  16 in total

1.  S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking.

Authors:  Kentaro Ozawa; Erin J Whalen; Christopher D Nelson; Yuanyu Mu; Douglas T Hess; Robert J Lefkowitz; Jonathan S Stamler
Journal:  Mol Cell       Date:  2008-08-08       Impact factor: 17.970

Review 2.  GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease.

Authors:  Alessandro Cannavo; Walter J Koch
Journal:  Cell Signal       Date:  2017-01-07       Impact factor: 4.315

Review 3.  Cardiac sympathetic innervation, from a different point of (re)view.

Authors:  Tania Zaglia; Marco Mongillo
Journal:  J Physiol       Date:  2017-06-15       Impact factor: 5.182

4.  Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide Pathway.

Authors:  Malapaka Kiranmayi; Venkat R Chirasani; Prasanna K R Allu; Lakshmi Subramanian; Elizabeth E Martelli; Bhavani S Sahu; Durairajpandian Vishnuprabu; Rathnakumar Kumaragurubaran; Saurabh Sharma; Dhanasekaran Bodhini; Madhulika Dixit; Arasambattu K Munirajan; Madhu Khullar; Venkatesan Radha; Viswanathan Mohan; Ajit S Mullasari; Sathyamangla V Naga Prasad; Sanjib Senapati; Nitish R Mahapatra
Journal:  Hypertension       Date:  2016-06-20       Impact factor: 10.190

5.  Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an "autoimmune" orthostatic hypotension.

Authors:  Xichun Yu; Stavros Stavrakis; Michael A Hill; Shijun Huang; Sean Reim; Hongliang Li; Muneer Khan; Sean Hamlett; Madeleine W Cunningham; David C Kem
Journal:  J Am Soc Hypertens       Date:  2011-11-30

6.  Rat mesenteric small artery neurogenic dilatation is predominantly mediated by β1 -adrenoceptors in vivo.

Authors:  Asger Maare Søndergaard; Cathrine Bang Overgaard; Aleksandra Mazur; Dmitry D Postnov; Vladimir V Matchkov; Christian Aalkjaer
Journal:  J Physiol       Date:  2019-02-21       Impact factor: 5.182

7.  Implications of a vasodilatory human monoclonal autoantibody in postural hypotension.

Authors:  Hongliang Li; Jonathan Zuccolo; David C Kem; Caitlin Zillner; Jiyeon Lee; Kenneth Smith; Judith A James; Madeleine W Cunningham; Xichun Yu
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

Review 8.  Perivascular innervation: a multiplicity of roles in vasomotor control and myoendothelial signaling.

Authors:  Erika B Westcott; Steven S Segal
Journal:  Microcirculation       Date:  2013-04       Impact factor: 2.628

9.  β3-adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling.

Authors:  Massimo Dal Monte; Irene Fornaciari; Grazie Paola Nicchia; Maria Svelto; Giovanni Casini; Paola Bagnoli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-03-06       Impact factor: 3.000

10.  Inhibition of vascular smooth muscle G protein-coupled receptor kinase 2 enhances alpha1D-adrenergic receptor constriction.

Authors:  Heather Irina Cohn; David M Harris; Stephanie Pesant; Michael Pfeiffer; Rui-Hai Zhou; Walter J Koch; Gerald W Dorn; Andrea D Eckhart
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-22       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.